Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

OGN

Organon & Co

Feb 13 • 12:41PM ET

7.20

+0.14 1.91 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Feb 12, 4:51 PMOrganon posts FY2025 revenue of $6.2B with net income down 78% to $187M and Q4 non-GAAP EPS $0.63 on $1.5B revenue, missing estimates; FDA approves an sNDA extending Nexplanon’s labeled duration from three to five years. On its call, the company announced a $390M sale of the Jada system, directing proceeds to debt reduction as it guides roughly flat 2026 and prioritizes deleveraging.

Peers: PFE MRK JNJ NVS ABBV LLY BMY GSK AZN-D BIIB

| Held by: IJR VTI VB VBR VXF FXH IJS SPSM SLYV SCHA

Index	-	P/E	3.74	EPS (ttm)	1.92	Insider Own	0.40%	Shs Outstand	259.98M	Perf Week	-12.36%
Market Cap	1.87B	Forward P/E	1.90	EPS next Y	3.79	Insider Trans	6.71%	Shs Float	258.95M	Perf Month	-16.43%
Enterprise Value	10.03B	PEG	0.76	EPS next Q	0.90	Inst Own	72.78%	Short Float	5.56%	Perf Quarter	-6.68%
Income	501.00M	P/S	0.30	EPS this Y	0.31%	Inst Trans	-4.74%	Short Ratio	2.63	Perf Half Y	-23.37%
Sales	6.30B	P/B	2.06	EPS next Y	3.15%	ROA	3.81%	Short Interest	14.39M	Perf YTD	0.35%
Book/sh	3.48	P/C	2.78	EPS next 5Y	2.49%	ROE	71.62%	52W High	17.23 -58.24%	Perf Year	-55.91%
Cash/sh	2.58	P/FCF	2.41	EPS past 3/5Y	-14.47% -23.49%	ROIC	5.17%	52W Low	6.18 16.43%	Perf 3Y	-75.59%
Dividend Est.	0.06 (0.89%)	EV/EBITDA	6.06	Sales past 3/5Y	0.22% -7.65%	Gross Margin	55.04%	Volatility	5.69% 5.27%	Perf 5Y	-
Dividend TTM	0.34 (4.73%)	EV/Sales	1.59	EPS Y/Y TTM	-61.89%	Oper. Margin	20.84%	ATR (14)	0.44	Perf 10Y	-
Dividend Ex-Date	Nov 20, 2025	Quick Ratio	1.20	Sales Y/Y TTM	-1.69%	Profit Margin	7.95%	RSI (14)	34.06	Recom	3.60
Dividend Gr. 3/5Y	25.99% -	Current Ratio	1.75	EPS Q/Q	-55.59%	SMA20	-15.30%	Beta	0.58	Target Price	9.21
Payout	33.59%	Debt/Eq	9.74	Sales Q/Q	1.26%	SMA50	-8.41%	Rel Volume	0.52	Prev Close	7.06
Employees	10000	LT Debt/Eq	9.69	Earnings	Feb 12 AMC	SMA200	-19.18%	Avg Volume	5.47M	Price	7.20
IPO	May 14, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-13.34% -1.81%	Trades		Volume	1,470,425	Change	1.91%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-25	Initiated	Barclays	Underweight	$7.50
Oct-27-25	Downgrade	Piper Sandler	Overweight → Underweight	$5
May-02-25	Downgrade	Evercore ISI	Outperform → In-line
Sep-06-24	Downgrade	JP Morgan	Neutral → Underweight	$18 → $20
Nov-03-23	Downgrade	Goldman	Buy → Neutral	$33 → $16
Sep-21-23	Initiated	Barclays	Overweight	$28
Mar-16-23	Initiated	Raymond James	Outperform	$33
Oct-14-22	Downgrade	BofA Securities	Neutral → Underperform	$27 → $25
Sep-06-22	Upgrade	Piper Sandler	Neutral → Overweight	$37 → $34
Aug-05-22	Downgrade	BofA Securities	Buy → Neutral	$40 → $37
Apr-27-22	Initiated	Goldman	Buy	$40
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$35
Oct-07-21	Initiated	Piper Sandler	Neutral	$35
Sep-01-21	Initiated	BofA Securities	Buy	$43
Jul-22-21	Initiated	Citigroup	Buy	$35
Jun-15-21	Initiated	JP Morgan	Neutral	$38
Jun-11-21	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-10-21	Initiated	Evercore ISI	Outperform

Show Previous Ratings

Today 01:09AM	Organon & Co. Q4 Earnings Call Highlights (MarketBeat)
12:34AM	OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook (StockStory)
Feb-12-26 04:32PM	Organon & Co. Q4 2025 Earnings Call Summary (Moby) -8.19%
04:04PM	Organon & Co (OGN) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
10:30AM	Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:50AM	Loading…
08:50AM	Organon (OGN) Misses Q4 Earnings and Revenue Estimates (Zacks)
08:01AM	Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations (StockStory)
07:51AM	Organon: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 (Business Wire)
Feb-10-26 10:05PM	Organon Earnings: What To Look For From OGN (StockStory)
Feb-02-26 05:50PM	Organon (OGN) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Jan-29-26 01:28PM	Organon Completes Divesture of JADA System to Laborie Medical (Zacks)
Jan-28-26 12:45PM	Organon Completes Divestiture of JADA System to Laborie (Business Wire)
Jan-27-26 05:50PM	Organon (OGN) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-22-26 06:46AM	Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report (Benzinga)
06:00PM	Loading…
Jan-21-26 06:00PM	Organon (OGN) Outperforms Broader Market: What You Need to Know (Zacks)
Jan-20-26 03:10PM	Why Are Organon (OGN) Shares Soaring Today (StockStory) +7.99%
11:04AM	Organon Secures FDA Approval Extending NEXPLANON Use to Five Years (Zacks)
10:31AM	Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report (Benzinga)
Jan-16-26 09:12PM	Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON (etonogestrel implant) 68 mg Radiopaque (Business Wire)
08:53AM	JPM26: AbbVie highlights growth drivers as it moves away from Humira dependency (Pharmaceutical Technology)
Jan-15-26 05:50PM	Organon (OGN) Exceeds Market Returns: Some Facts to Consider (Zacks)
Jan-14-26 06:00PM	Organon (OGN) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Jan-08-26 01:30AM	Organon Enters into a Commercialization Agreement for Daiichi Sankyos Nilemdo in France, Denmark, Iceland, Sweden, Finland and Norway (Business Wire)
Jan-05-26 06:00PM	Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing (Zacks) +8.47%
Dec-24-25 09:00AM	Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock (Zacks)
Dec-22-25 05:50PM	Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Dec-12-25 09:00AM	Is Trending Stock Organon & Co. (OGN) a Buy Now? (Zacks)
Dec-09-25 04:01PM	Why Organon (OGN) Shares Are Trading Lower Today (StockStory)
Dec-01-25 09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
11:03PM	Loading…
Nov-30-25 11:03PM	Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Nov-25-25 10:32PM	Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks (StockStory) +6.37%
07:30AM	Organon To Present at the Piper Sandler 37th Annual Healthcare Conference (Business Wire)
Nov-18-25 09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Nov-17-25 01:14PM	Henlius and Organon score first US Perjeta biosimilar approval (Pharmaceutical Technology)
05:30AM	Henlius and Organon Announce US FDA Approval of POHERDY (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US (Business Wire)
12:34AM	The 5 Most Interesting Analyst Questions From Organon's Q3 Earnings Call (StockStory)
Nov-11-25 12:50PM	Organon & Co. (OGN) Climbs 13.7% Ahead of Dividends (Insider Monkey)
12:26PM	Organon (OGN) Stock Trades Down, Here Is Why (StockStory)
12:31AM	OGN Q3 2025 Deep Dive: Leadership Changes, Portfolio Shifts, and Guidance Recalibration (StockStory)
Nov-10-25 04:01PM	Organon & Co (OGN) Q3 2025 Earnings Call Highlights: Strong Biosimilars Performance Amidst ... (GuruFocus.com) +13.72%
01:30PM	Organon (OGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
10:06AM	Laborie inks $465M deal to buy post-childbirth device from Organon (MedTech Dive)
08:45AM	Organon (OGN) Q3 Earnings and Revenues Beat Estimates (Zacks)
08:01AM	Organon (NYSE:OGN) Posts Better-Than-Expected Sales In Q3 (StockStory)
07:45AM	Organon: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Organon Reports Results for the Third Quarter Ended September 30, 2025 (Business Wire)
Nov-08-25 10:02PM	Organon (OGN) Reports Earnings Tomorrow: What To Expect (StockStory)
Nov-07-25 12:50PM	Organon divests JADA system to Laborie in $465m deal (Medical Device Network)
07:30AM	Organon Announces Agreement to Divest its JADA System for Up to $465 Million to Laborie (Business Wire)
Nov-06-25 07:30AM	Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025 (Business Wire) +5.17%
Oct-30-25 04:56AM	Jim Cramer's "Worst Stock Ever" Might Be Organon (OGN) (Insider Monkey)
Oct-28-25 03:21PM	Why Organon (OGN) Stock Is Down Today (StockStory) -5.67%
Oct-27-25 01:30PM	Organon CEO stands down amid contraceptive sales malpractice probe (Medical Device Network) -22.93%
01:26PM	This Drugmaker Made 'Improper' Sales to Meet Guidance. The Stock Plummets 25%. (Barrons.com)
Oct-23-25 05:50PM	Organon (OGN) Laps the Stock Market: Here's Why (Zacks)
10:00AM	Organon (OGN) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-22-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Oct-21-25 09:00AM	Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Oct-17-25 05:50PM	Organon (OGN) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Oct-16-25 06:00PM	Organon (OGN) Dips More Than Broader Market: What You Should Know (Zacks)
08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Oct-08-25 11:32PM	Q2 Earnings Highs And Lows: Organon (NYSE:OGN) Vs The Rest Of The Branded Pharmaceuticals Stocks (StockStory)
09:00AM	Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know (Zacks)
Oct-06-25 06:00PM	Organon (OGN) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
12:10PM	Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
12:02AM	3 Reasons to Avoid OGN and 1 Stock to Buy Instead (StockStory)
Sep-29-25 05:50PM	Organon (OGN) Outperforms Broader Market: What You Need to Know (Zacks)
Sep-25-25 06:00PM	Here's Why Organon (OGN) Fell More Than Broader Market (Zacks)
Sep-24-25 09:00AM	Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock (Zacks)
Sep-19-25 05:50PM	Organon (OGN) Stock Dips While Market Gains: Key Facts (Zacks)
06:00AM	European Commission (EC) Approves Henlius and Organons BILDYOS (denosumab) and BILPREVDA (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively (Business Wire)
Sep-12-25 09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Sep-11-25 11:55AM	Why Organon (OGN) Stock Is Trading Up Today (StockStory)
12:35AM	3 Stocks Under $50 We Find Risky (StockStory)
Sep-10-25 05:50PM	Organon (OGN) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Sep-02-25 05:30AM	US Food and Drug Administration (FDA) Approves Henlius and Organons BILDYOS (denosumab-nxxp) and BILPREVDA (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively (Business Wire)
Aug-29-25 05:04AM	Organon & Co. (OGN) Advances VTAMA Cream, Strengthens Women's Health Portfolio (Insider Monkey)
Aug-25-25 09:00AM	Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Aug-13-25 12:10AM	OGN Q2 Deep Dive: Flat Sales, Margin Pressure, and Strategic Shifts Highlight Quarter (StockStory)
12:02AM	5 Must-Read Analyst Questions From Organon's Q2 Earnings Call (StockStory)
Aug-12-25 09:00AM	Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know (Zacks)
08:00AM	Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors (Business Wire)
Aug-08-25 11:40AM	OGN vs. HQY: Which Stock Is the Better Value Option? (Zacks)
Aug-07-25 01:01PM	Organon & Co. (OGN) Reports Q2 2025 Results (Insider Monkey)
Aug-06-25 12:22PM	Organon & Co. (OGN) Slashes 13.13% on Disappointing Earnings (Insider Monkey)
Aug-05-25 11:00AM	Organon (OGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -13.13%
08:45AM	Organon (OGN) Beats Q2 Earnings and Revenue Estimates (Zacks)
08:04AM	Organon (NYSE:OGN) Surprises With Q2 Sales, Stock Soars (StockStory)
07:42AM	Organon: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Organon Reports Results for the Second Quarter Ended June 30, 2025 (Business Wire)
Aug-04-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Aug-03-25 11:07PM	Organon Earnings: What To Look For From OGN (StockStory)
Aug-01-25 09:15AM	Insights Into Organon (OGN) Q2: Wall Street Projections for Key Metrics (Zacks)
Jul-31-25 05:50PM	Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Jul-30-25 10:00AM	Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-29-25 10:00AM	Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jul-25-25 05:50PM	Organon (OGN) Outperforms Broader Market: What You Need to Know (Zacks)
Jul-23-25 09:00AM	Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock (Zacks)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COX CARRIE SMITH	Executive Chair	Nov 12 '25	Buy	7.67	65,400	501,755	77,869	Nov 13 04:05 PM
Drinane Juliana Papa	Interim Head of Mfg & Supply	Nov 07 '25	Option Exercise	0.00	3,626	0	18,417	Nov 12 05:48 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Nov 07 '25	Option Exercise	0.00	6,446	0	31,223	Nov 10 04:14 PM
Holzbaur Lynette	SVP and Corporate Controller	Nov 07 '25	Option Exercise	0.00	2,417	0	15,365	Nov 10 04:04 PM
Holzbaur Lynette	SVP and Corporate Controller	Nov 05 '25	Option Exercise	0.00	3,037	0	13,814	Nov 06 04:11 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Aug 11 '25	Option Exercise	0.00	11,519	0	28,899	Aug 12 04:05 PM
COX CARRIE SMITH	Director	May 14 '25	Buy	8.07	12,469	100,591	12,469	May 15 04:09 PM
Falcione Aaron	Chief Human Resources Officer	May 07 '25	Buy	8.77	5,500	48,235	62,974	May 07 12:13 PM
Weaver Kirke	Gen. Counsel & Corp. Secy.	May 06 '25	Buy	9.21	8,045	74,054	52,489	May 07 12:12 PM
Karp Daniel	Executive VP, Corp. Dev.	May 06 '25	Buy	8.24	3,500	28,828	46,669	May 07 12:09 PM
WALSH MATTHEW M	Chief Financial Officer	May 05 '25	Buy	8.82	11,400	100,548	144,484	May 06 01:59 PM
Ali Kevin	Chief Executive Officer	May 05 '25	Buy	8.80	34,000	299,370	282,731	May 06 01:58 PM
Falcione Aaron	Chief Human Resources Officer	Mar 31 '25	Option Exercise	0.00	18,732	0	59,237	Apr 02 05:45 PM
Karp Daniel	Executive VP, Corp. Dev.	Mar 31 '25	Option Exercise	0.00	34,677	0	44,515	Apr 02 05:44 PM
Stahler Rachel A	Chief Information Officer	Mar 31 '25	Option Exercise	0.00	18,334	0	78,994	Apr 02 05:43 PM
WALSH MATTHEW M	Chief Financial Officer	Mar 31 '25	Option Exercise	0.00	34,870	0	136,903	Apr 02 05:41 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Mar 31 '25	Option Exercise	0.00	8,865	0	20,552	Apr 02 05:40 PM
Weaver Kirke	Gen. Counsel & Corp. Secy.	Mar 31 '25	Option Exercise	0.00	21,376	0	45,668	Apr 02 05:39 PM
DiMarco Kathryn	Corporate Controller	Mar 31 '25	Option Exercise	0.00	23,435	0	40,211	Apr 02 05:35 PM
Nisita Vittorio	Head of Global Business Svcs	Mar 31 '25	Option Exercise	0.00	13,231	0	44,803	Apr 02 05:34 PM
Morrissey Joseph T. Jr.	Head of Manufacturing	Mar 31 '25	Option Exercise	0.00	21,483	0	73,275	Apr 02 05:33 PM
Ali Kevin	Chief Executive Officer	Mar 31 '25	Option Exercise	0.00	109,204	0	260,687	Apr 02 05:32 PM

Open in Screener

TXN

Texas Instruments Inc

Feb 13 • 12:41PM ET

224.67

+1.67 0.75 %

Technology • Semiconductors • USA • NASD

TXN Texas Instruments Inc daily Stock Chart

Peers: ADI ON MCHP AVGO SWKS QRVO NXPI STM AMD

| Held by: VTI QQQ VOO SCHD IVV SPY SMH XLK VGT SOXX

Index	NDX, S&P 500	P/E	41.26	EPS (ttm)	5.45	Insider Own	0.18%	Shs Outstand	907.00M	Perf Week	1.46%
Market Cap	203.90B	Forward P/E	29.35	EPS next Y	7.66	Insider Trans	-7.08%	Shs Float	905.93M	Perf Month	16.14%
Enterprise Value	213.80B	PEG	1.64	EPS next Q	1.36	Inst Own	88.33%	Short Float	2.47%	Perf Quarter	37.76%
Income	4.97B	P/S	11.53	EPS this Y	17.76%	Inst Trans	0.17%	Short Ratio	2.83	Perf Half Y	15.98%
Sales	17.68B	P/B	12.52	EPS next Y	19.29%	ROA	14.19%	Short Interest	22.35M	Perf YTD	29.50%
Book/sh	17.94	P/C	41.77	EPS next 5Y	17.91%	ROE	29.98%	52W High	231.32 -2.88%	Perf Year	24.26%
Cash/sh	5.38	P/FCF	78.33	EPS past 3/5Y	-16.65% -1.81%	ROIC	16.34%	52W Low	139.95 60.53%	Perf 3Y	27.14%
Dividend Est.	5.71 (2.54%)	EV/EBITDA	26.27	Sales past 3/5Y	-4.07% 4.10%	Gross Margin	57.02%	Volatility	3.08% 3.12%	Perf 5Y	25.07%
Dividend TTM	5.56 (2.47%)	EV/Sales	12.09	EPS Y/Y TTM	4.53%	Oper. Margin	34.72%	ATR (14)	6.61	Perf 10Y	339.32%
Dividend Ex-Date	Jan 30, 2026	Quick Ratio	2.83	Sales Y/Y TTM	13.05%	Profit Margin	28.12%	RSI (14)	68.43	Recom	2.61
Dividend Gr. 3/5Y	5.45% 8.13%	Current Ratio	4.35	EPS Q/Q	-2.74%	SMA20	5.97%	Beta	0.98	Target Price	222.62
Payout	100.97%	Debt/Eq	0.91	Sales Q/Q	10.38%	SMA50	16.08%	Rel Volume	0.33	Prev Close	223.00
Employees	33000	LT Debt/Eq	0.87	Earnings	Jan 27 AMC	SMA200	19.96%	Avg Volume	7.90M	Price	224.67
IPO	Oct 01, 1953	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1.22% -0.32%	Trades		Volume	1,340,387	Change	0.75%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-28-26	Upgrade	BofA Securities	Underperform → Neutral	$235
Jan-28-26	Reiterated	TD Cowen	Buy	$225 → $240
Jan-22-26	Upgrade	BNP Paribas Exane	Underperform → Neutral	$190
Dec-15-25	Downgrade	Goldman	Buy → Sell	$156
Oct-23-25	Reiterated	Robert W. Baird	Outperform	$220 → $195
Oct-22-25	Reiterated	TD Cowen	Buy	$210 → $200
Oct-20-25	Downgrade	Mizuho	Neutral → Underperform	$150
Oct-13-25	Downgrade	BofA Securities	Neutral → Underperform	$190
Jul-28-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$230
Jul-23-25	Reiterated	Wells Fargo	Equal Weight	$215 → $195
Jul-23-25	Reiterated	Truist	Hold	$171 → $196
Jul-23-25	Reiterated	The Benchmark Company	Buy	$200 → $220
Jul-23-25	Reiterated	TD Cowen	Buy	$245 → $230
Jul-23-25	Reiterated	Susquehanna	Positive	$250 → $240
Jul-23-25	Reiterated	Robert W. Baird	Outperform	$175 → $220
Jul-23-25	Reiterated	Mizuho	Neutral	$205 → $200
Jul-23-25	Downgrade	DZ Bank	Hold → Sell	$158
Jul-21-25	Upgrade	Seaport Research Partners	Sell → Neutral
Jul-11-25	Upgrade	TD Cowen	Hold → Buy	$245
Jul-10-25	Initiated	Goldman	Buy	$255

Show Previous Ratings

Feb-11-26 11:04PM	Texas Instruments (TXN): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
11:23AM	Stocks Turn Mixed as Software Stocks Slide (Barchart)
09:45AM	Here's Why Texas Instruments (TXN) is a Strong Growth Stock (Zacks)
08:18AM	Should You Be Optimistic on Texas Instruments' (TXN) Growth Potential? (Insider Monkey)
Feb-10-26 09:15AM	Texas Instruments (TXN) Reliance on International Sales: What Investors Need to Know (Zacks)
10:01AM	Loading…
Feb-09-26 10:01AM	Stocks Slip Ahead of this Week's US News on Jobs and Inflation (Barchart)
Feb-07-26 07:37AM	Texas Instruments Executes a $7.5B Deal and an AI Strategy Pivot (MarketBeat)
Feb-06-26 08:50AM	Multi-Billion-Dollar VRU Detection Market Unlocking New Growth Opportunities (PR Newswire)
08:05AM	Silicon Labs price target raised to $205 from $160 at RBC Capital (TipRanks)
Feb-05-26 11:36PM	2 Large-Cap Stocks Worth Your Attention and 1 Facing Challenges (StockStory)
03:39PM	Laid Off? Here's How ETFs Fit Into Financial Planning After Job Loss (Benzinga)
12:20PM	Is It Too Late to Buy Silicon Labs Stock? (Barchart)
09:00AM	Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results (TipRanks)
Feb-04-26 10:46PM	Texas Instruments to reshore Silicon Labs production in US$7.5 billion wireless play (DigiTimes)
08:37PM	Texas Instruments makes a $7.5B deal no one saw coming (TheStreet)
06:15PM	Loading…
06:15PM	Silicon Labs Stock Rockets On Texas Instruments Buyout (Investor's Business Daily)
05:28PM	Stocks to Watch Wednesday Recap: AMD, Super Micro, Chipotle (The Wall Street Journal)
04:16PM	Silicon Labs Stock Soars. Why Texas Instruments Is Paying a Big Premium for the Acquisition. (Barrons.com)
04:06PM	Apple stock gains amid tech sell-off, Yum! Brands' mixed Q4 results (Yahoo Finance Video)
03:20PM	Texas Instruments to acquire Silicon Labs in $7.5B all-cash deal (Proactive)
02:34PM	Texas Instruments Agrees $7.5 Billion Silicon Labs Deal as Shares Jump 51% (GuruFocus.com)
12:43PM	Texas Instruments to buy Silicon Labs in $7.5 billion deal (CNBC TV)
12:22PM	Analyst Report: Texas Instruments Incorporated (Morningstar Research)
12:04PM	Why Silicon Labs Stock Glows Green Today (Motley Fool)
10:42AM	Texas Instruments to buy Silicon Labs, Enphase stock surges 40% (Yahoo Finance Video)
10:10AM	Texas Instruments to Buy Silicon Labs for $231/Share, Targets $450M Synergies by 2030 (MarketBeat)
09:39AM	Stocks to Watch Wednesday: AMD, Super Micro, Chipotle (The Wall Street Journal)
09:30AM	Big Bang Semiconductor Deal: Texas Instruments Snaps Silicon Labs For $7.5 Billion (Benzinga)
09:00AM	Is Trending Stock Texas Instruments Incorporated (TXN) a Buy Now? (Zacks)
08:24AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:29AM	Loading…
07:29AM	Texas Instruments to Acquire Silicon Labs in Deal Valued at $7.5 Billion (The Wall Street Journal)
07:24AM	Silicon Labs Stock Surges. Why Texas Instruments Is Buying the Chip Company. (Barrons.com)
07:05AM	Texas Instruments to buy chip designer Silicon Labs in $7.5 billion deal (Reuters)
07:00AM	Texas Instruments to acquire Silicon Labs (PR Newswire)
Feb-03-26 11:57PM	Silicon Laboratories (SLAB) Shares Jumped Over 33% In After-Hours Trading On Texas Instruments Deal Buzz: What's Going On (Benzinga)
08:49PM	Texas Instruments Incorporated (TXN): A Bull Case Theory (Insider Monkey)
06:24PM	Silicon Labs Stock Pops on Report of Deal With Texas Instruments (Barrons.com)
06:24PM	Silicon Labs Stock Pops on Report of Deal Talks With Texas Instruments (Barrons.com)
04:21PM	Texas Instruments in advanced talks to buy chip designer Silicon Laboratories (Financial Times)
04:11PM	Texas Instruments in advanced talks to buy Silicon Laboratories for about $7 billion, source says (Reuters)
11:34AM	Jim Cramer on Texas Instruments: "I Think It's Really Worth Watching" (Insider Monkey)
09:59AM	Nasdaq Slips, Gold and Silver Stage Substantial Recovery (Barchart)
09:28AM	Texas Instruments Stock: Is Wall Street Bullish or Bearish? (Barchart)
12:35AM	The Top 5 Analyst Questions From Texas Instruments's Q4 Earnings Call (StockStory)
Feb-02-26 11:19AM	Stocks Gain on US Manufacturing Strength (Barchart)
09:50AM	Why Texas Instruments (TXN) is a Top Momentum Stock for the Long-Term (Zacks)
Feb-01-26 08:19AM	Consumer Tech News (Jan 26-30): Meta Faces Lawsuits Over Youth Addiction Claims, IMF Warns AI Could Eliminate Millions Of Jobs & More (Benzinga)
Jan-31-26 08:30AM	These overlooked stocks are a backdoor way to play the AI chip boom (MarketWatch)
Jan-30-26 05:12PM	Why Texas Instruments Stock Was a Monster Winner This Week (Motley Fool)
02:36PM	Micron Stock Hits Record High -- Insiders Are Selling (GuruFocus.com)
11:16AM	Stocks Slip as Bond Yields Rise after Warsh Picked for Fed Chair (Barchart)
10:00AM	Stocks Fall as Trump Nominates Warsh for Fed Chair (Barchart)
08:24AM	Texas Instruments (TXN) "is Crushing it," Says Jim Cramer (Insider Monkey)
07:47AM	Pay Attention: QQQEs Dividend Dropped By A Third While QQQ Paid 5 Times More (24/7 Wall St.)
03:00AM	Micron Stock Keeps Climbing-And a Top Executive May Have Sold Too Soon (Barrons.com)
Jan-29-26 11:35PM	What Anthropic and OpenAI's Recent News Mean for AI Stock Investors (Motley Fool)
06:30PM	Why Texas Instruments' 2026 Outlook Has Wall Street Re-Rating It (MarketBeat)
12:00PM	What Makes Texas Instruments (TXN) a Strong Momentum Stock: Buy Now? (Zacks)
09:41AM	PayPal downgraded, UPS upgraded: Wall Streets top analyst calls (TipRanks)
08:55AM	Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Computer and Technology Names (Zacks)
06:28AM	Stocks Rise Before the Open as Investors Weigh Big Tech Earnings, U.S. Economic Data and Apple Results in Focus (Barchart)
02:07AM	Wall Street Backs Texas Instruments (TXN) Ahead of Q4 Earnings and Capital Management Day (Insider Monkey)
Jan-28-26 11:04PM	How Texas Instruments Stock Jumped 9.9% Wednesday (Motley Fool) +9.94%
04:32PM	Stocks Finish Mixed as Fed Keeps Interest Rates Steady (Barchart)
04:29PM	These Stocks Are Todays Movers: Seagate, Amphenol, Texas Instruments, Nvidia, Tesla, AT&T, Nextpower, and More (Barrons.com)
04:08PM	Intel, Micron, These Other Chip Stocks Are Rallying. Thank Texas Instruments and ASML. (Barrons.com)
04:02PM	Chip Makers Point to Accelerating Demand. It's a Big Deal. (Barrons.com)
02:21PM	Texas Instruments Gains After Analysts Point To Improving Orders, Early Signs Of Chip Cycle Recovery (Benzinga)
01:25PM	TI to webcast capital management presentation (PR Newswire)
01:01PM	Gold Rallies To $5,300, Memory Stocks Go Wild: What's Moving Markets Wednesday? (Benzinga)
12:50PM	Why Are Texas Instruments (TXN) Shares Soaring Today (StockStory)
12:11PM	The S&P 500 Is Flat. The Battle for 7000 Continues. (Barrons.com)
11:26AM	Texas Instruments Stock Pops on Q1 Forecast (Schaeffer's Research)
11:15AM	Stocks Mixed After the Fed Pauses Rate Cuts (Barchart)
10:54AM	Texas Instruments Forecast Tops Estimates as Industrial Demand Improves (GuruFocus.com)
10:51AM	Texas Instruments' Forecast Shows Semiconductor ETFs Are No Longer Just An Nvidia Trade (Benzinga)
10:21AM	Texas Instruments, Circle, Johnson & Johnson: Top Analyst Calls (Yahoo Finance Video)
10:21AM	S&P 500 breaches 7,000 as tech giants Microsoft and Meta prep earnings (Investing.com)
09:57AM	Texas Instruments Rallies After Chip Rebound Gains Momentum (Bloomberg)
09:49AM	ADI's Communications Segment Surges 26% in FY25: What's Next? (Zacks)
09:39AM	PayPal downgraded, UPS upgraded: Wall Street's top analyst calls (The Fly)
09:14AM	Texas Instruments Q4 Earnings Miss Estimates, Revenues Rise Y/Y (Zacks)
07:44AM	Texas Instruments Shares Jump 7% on Strong AI Data Center Demand Outlook (24/7 Wall St.)
07:06AM	Texas Instruments, ASML Lift Chip Stocks Higher (Benzinga)
06:28AM	S&P 500 Builds on Record. Tech Stocks Rally Ahead of Fed Rate Call. (Barrons.com)
06:26AM	Texas Instruments shares jump as first-quarter outlook signals robust AI data center demand (Reuters)
06:22AM	Nasdaq Futures Rally as ASML Provides a Boost, Fed Decision and Big Tech Earnings Awaited (Barchart)
05:41AM	Tech Stocks Rally Ahead of Fed Rate Call. Dollar Falls After Trump Rout. (Barrons.com)
05:28AM	Texas Instruments shares pop on earnings, and other early market movers (MarketWatch)
05:22AM	Intel, Micron and These Other Chip Stocks Are Rallying. Thank Texas Instruments and ASML. (Barrons.com)
12:36AM	TXN Q4 Deep Dive: End Market Recovery and Data Center Momentum Drive Optimism (StockStory)
12:01AM	Texas Instruments Inc (TXN) Q4 2025 Earnings Call Highlights: Strong Year-Over-Year Revenue ... (GuruFocus.com)
12:00AM	Analyst Report: Texas Instruments Incorporated (Morningstar Research)
Jan-27-26 11:18PM	Texas Instruments forecasts something that hasn't happened in 16 years, lifting its stock (MarketWatch)
08:24PM	Seagate Technology, Texas Instruments, Richtech Robotics, Corning And Lam Research: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)
08:05PM	TI sees uneven recovery: Industrial rebuilds and data center booms, but consumer electronics fade (DigiTimes)
08:02PM	TI accelerates capacity push, shrugs off memory shortages (DigiTimes)
06:14PM	Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into First Quarter (The Wall Street Journal)
05:52PM	Earnings and Home Prices and Confidence - Oh My! (Zacks)
05:37PM	Texas Instruments Q4 Earnings Call Highlights (MarketBeat)

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The Other segment includes DLP products, calculators, and custom application-specific integrated circuits products. The company was founded in 1930 and is headquartered in Dallas, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BAHAI AHMAD	Sr. Vice President	Feb 11 '26	Option Exercise	79.26	6,500	515,190	48,988	Feb 12 04:26 PM
BAHAI AHMAD	Sr. Vice President	Feb 11 '26	Sale	230.79	6,500	1,500,117	42,488	Feb 12 04:26 PM
Gary Mark	Sr. Vice President	Feb 11 '26	Option Exercise	110.15	12,921	1,423,248	58,468	Feb 12 04:26 PM
Gary Mark	Sr. Vice President	Feb 11 '26	Sale	230.10	12,921	2,973,107	45,547	Feb 12 04:26 PM
Gary Mark	Sr. Vice President	Feb 10 '26	Sale	220.83	10,248	2,263,098	45,547	Feb 12 04:26 PM
Lizardi Rafael R	Sr. Vice President & CFO	Feb 10 '26	Option Exercise	130.52	64,532	8,422,717	157,082	Feb 12 04:25 PM
Lizardi Rafael R	Sr. Vice President & CFO	Feb 10 '26	Sale	220.74	64,532	14,244,539	92,550	Feb 12 04:25 PM
Lizardi Rafael R	Sr. Vice President & CFO	Feb 11 '26	Sale	230.78	7,096	1,637,611	85,454	Feb 12 04:25 PM
Rafael Lizardi	Officer	Feb 11 '26	Proposed Sale	230.78	7,096	1,637,611		Feb 11 03:05 PM
Rafael Lizardi	Officer	Feb 10 '26	Proposed Sale	220.74	64,532	14,244,537		Feb 10 04:57 PM
Roberts Mark T.	Sr. Vice President	Feb 09 '26	Sale	221.16	4,461	986,604	64,058	Feb 10 04:28 PM
BLINN MARK A	Director	Feb 05 '26	Option Exercise	175.48	2,572	451,344	14,814	Feb 06 04:22 PM
BLINN MARK A	Director	Feb 05 '26	Sale	221.58	3,144	696,647	11,670	Feb 06 04:22 PM
BAHAI AHMAD	Sr. Vice President	Feb 05 '26	Option Exercise	79.26	3,000	237,780	45,488	Feb 06 04:22 PM
BAHAI AHMAD	Sr. Vice President	Feb 05 '26	Sale	223.46	3,000	670,387	42,488	Feb 06 04:22 PM
Richard K. Templeton	Former Chairman of the Board	Feb 05 '26	Proposed Sale	223.98	333,615	74,723,088		Feb 05 04:41 PM
Mark Blinn	Director	Feb 05 '26	Proposed Sale	221.58	3,144	696,647		Feb 05 02:07 PM
KIRK RONALD	Director	Nov 24 '25	Option Exercise	52.93	9,990	528,771	24,927	Nov 25 05:44 PM
KIRK RONALD	Director	Nov 24 '25	Sale	162.33	9,990	1,621,688	14,937	Nov 25 05:44 PM
RONALD KIRK	Officer	Nov 24 '25	Proposed Sale	162.33	9,990	1,621,688		Nov 24 04:01 PM
Witzsche Christine	Sr. Vice President	Nov 13 '25	Option Exercise	52.93	1,000	52,930	21,821	Nov 14 04:03 PM
Witzsche Christine	Sr. Vice President	Nov 13 '25	Sale	164.31	1,000	164,306	20,821	Nov 14 04:03 PM
CHRISTINE WITZSCHE	Officer	Nov 13 '25	Proposed Sale	164.31	1,000	164,306		Nov 13 03:19 PM
BLINN MARK A	Director	Jul 21 '25	Sale	216.75	0	72	3,046	Aug 27 01:35 PM
BAHAI AHMAD	Sr. Vice President	Aug 25 '25	Option Exercise	79.26	1,500	118,890	40,383	Aug 27 12:25 PM
BAHAI AHMAD	Sr. Vice President	Aug 25 '25	Sale	205.35	1,500	308,030	38,883	Aug 27 12:25 PM
TEMPLETON RICHARD K	Chairman	Feb 27 '25	Option Exercise	52.93	97,000	5,134,210	506,089	Mar 03 04:28 PM
TEMPLETON RICHARD K	Chairman	Feb 28 '25	Option Exercise	52.93	4,557	241,202	413,646	Mar 03 04:28 PM
TEMPLETON RICHARD K	Chairman	Feb 27 '25	Sale	195.47	97,000	18,960,307	409,089	Mar 03 04:28 PM
TEMPLETON RICHARD K	Chairman	Feb 28 '25	Sale	194.21	4,557	885,021	409,089	Mar 03 04:28 PM
TEMPLETON RICHARD K	Chairman	Feb 25 '25	Option Exercise	52.93	97,000	5,134,210	506,089	Feb 27 04:39 PM
TEMPLETON RICHARD K	Chairman	Feb 26 '25	Option Exercise	52.93	97,000	5,134,210	506,089	Feb 27 04:39 PM
TEMPLETON RICHARD K	Chairman	Feb 25 '25	Sale	200.72	97,000	19,469,888	409,089	Feb 27 04:39 PM
TEMPLETON RICHARD K	Chairman	Feb 26 '25	Sale	197.69	97,000	19,175,569	409,089	Feb 27 04:39 PM
CLARK JANET F	Director	Feb 24 '25	Option Exercise	79.26	6,065	480,712	16,881	Feb 25 05:29 PM
CLARK JANET F	Director	Feb 24 '25	Sale	203.62	6,065	1,234,956	10,816	Feb 25 05:29 PM
TEMPLETON RICHARD K	Chairman	Feb 21 '25	Option Exercise	52.93	97,000	5,134,210	506,089	Feb 25 05:26 PM
TEMPLETON RICHARD K	Chairman	Feb 24 '25	Option Exercise	52.93	97,000	5,134,210	506,089	Feb 25 05:26 PM
TEMPLETON RICHARD K	Chairman	Feb 21 '25	Sale	202.72	97,000	19,663,684	409,089	Feb 25 05:26 PM
TEMPLETON RICHARD K	Chairman	Feb 24 '25	Sale	202.68	97,000	19,660,139	409,089	Feb 25 05:26 PM
Janet Clark	Director	Feb 24 '25	Proposed Sale	203.46	6,065	1,234,000		Feb 24 03:15 PM
Richard K Templeton	Other: Chairman of the Board	Feb 21 '25	Proposed Sale	202.00	489,557	98,890,514		Feb 21 05:39 PM
BLINN MARK A	Director	Feb 19 '25	Option Exercise	171.55	6,186	1,061,238	17,903	Feb 20 04:05 PM
BLINN MARK A	Director	Feb 19 '25	Sale	189.89	6,186	1,174,646	11,717	Feb 20 04:05 PM
Leonard Shanon J	Sr. Vice President	Feb 18 '25	Sale	186.62	2,150	401,241	27,016	Feb 19 04:08 PM
MARK A BLINN	Officer	Feb 19 '25	Proposed Sale	189.89	6,186	1,174,646		Feb 19 02:46 PM
Shanon J. Leonard	Officer	Feb 18 '25	Proposed Sale	186.51	2,150	401,000		Feb 18 05:28 PM

OGN

Organon & Co

TXN

Texas Instruments Inc

Upgrade your FINVIZ experience